bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
Conditions: Liver Diseases; Hepatocellular Carcinoma; Immunotherapy; Camrelizumab; Lenvatinib Interventions: Procedure: bTAE-HAIC; Drug: Lenvatinib; Drug: Camrelizumab Sponsors: Zhou Qunfang Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Liver Disease | Research | Urology & Nephrology